Chemical Compound
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-; N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide; ACT 064992; Macitentan; Opsumit; Propylsulfamic acid N-[5-(4-bromophenyl)-6-[2-[(5-bromopyrimidin-2-yl)oxy]ethoxy]pyrimidin-4-yl]amide
CAS Registry Number
441798-33-0
Primary record
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-; N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide; ACT 064992; Macitentan; Opsumit; Propylsulfamic acid N-[5-(4-bromophenyl)-6-[2-[(5-bromopyrimidin-2-yl)oxy]ethoxy]pyrimidin-4-yl]amide
- 库存
- 4,914 克
- 纯度
- 98.9 %
- CAS
- 441798-33-0
化合物标识与属性
- CAS
- 441798-33-0
- PubChem CID
- 16004692
- SMILES
- CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
- Canonical SMILES
- CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
名称与同义词
- Macitentan
- Opsumit
- 441798-33-0
- Actelion-1
- macitentanum
- Macitentan D4
- Macitentan-d4
- Macitentan [INN]
- ACT-064992
- zlchem 5
- Opsumit (TN)
- Z9K9Y9WMVL
- Macitentan (Standard)
- Macitentan [USAN:INN]
- UNII-Z9K9Y9WMVL
- ACT 064992
- MACITENTAN [MI]
- RefChem:58979
- Unable to generate value
- MACITENTAN [JAN]
- Macitentan (JAN/USAN)
- MACITENTAN [USAN]
- ACT064992
- MACITENTAN [VANDF]
- C19H20Br2N6O4S
- D0S7JH
- (non-labelled)Macitentan-d7
- A1D5I
- MACITENTAN [WHO-DD]
- MFCD17167076
- CHEBI:76607
- MLS006011174
- DTXSID50196063
- GTPL7352
- Macitentan - Bio-X trade mark
- OPSYNVI COMPONENT MACITENTAN
- orb1305317
- SCHEMBL1445625
- CHEMBL2103873
- MACITENTAN [ORANGE BOOK]
- SCHEMBL29378853
- C02KX04
- DTXCID60118554
- EX-A544
- ZLA0005
- JGCMEBMXRHSZKX-UHFFFAOYSA-N
- GLXC-90056
- HMS3653N06
- HMS3747E09
- HMS5086O05
- cas:441798-33-0;Macitentan
- AOB87765
- BCP05309
- IAC42805
- KS-000005UM
- ABP001066
- BDBM50395626
- EBC-27358
- HY-14184R
- s8051
- ZINC43202140
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
- AKOS024463406
- ACN-034475
- AM81244
- CCG-270155
- CS-0686
- DB08932
- FM65071
- SB14841
- Macitentan (Actelion-1,ACT-064992)
- NCGC00346456-01
- NCGC00346456-05
- AC-30102
- AK162704
- AS-74590
- BC600464
- BM162771
- CID:16004692
- HY-14184
- QC-10426
- SMR004702943
- Macitentan (Actelion-1,ACT-064992)?
- SID:252166931
- AB0007893
- DB-070519
- FT-0696675
- NS00072551
- ST24048423
- SW219473-1
- X6162
- J2.832.870B
- A11492
- ACT 064992; ACT-064992
- D10135
- Opsynvi (combination of macitentan + tadalafil)
- S-7749
- EN300-7404089
- 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine
- A854671
- C533860
- N-(5-(4-Bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)-N'-propylsulfamide
- Q6724151
- BRD-K48812570-001-02-3
- BRD-K48812570-001-03-1
- B0084-092460
- {[5-(4-BROMOPHENYL)-6-{2-[(5-BROMOPYRIMIDIN-2-YL)OXY]ETHOXY}PYRIMIDIN-4-YL]SULFAMOYL}(PROPYL)AMINE
- 1258428-05-5
- n-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-n'-propylaminosulfonamide
- N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXI)ETHOXY)PYRIMIDIN-4-YL)-N'-PROPYLSULFURIC DIAMIDE
- N-(5-(4-Bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)-N'-propylsulfamide
- N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'- propylsulfamide
- N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'-propylsulfuric diamide
- ((5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)sulfamoyl)(propyl)amine
- 1103522-45-7
- 441798-65-8
- 5-(p-Bromophenyl)-6-[2-(5-bromo-2-pyrimidinyloxy)ethoxy]-4-(propylaminosulfonylamino)pyrimidine
- N-(5-(4-Bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)-N'-propylsulfuric diamide
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)-oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N -propylsulfamide
- n-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-n'-propyl-sulfamide
- Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-
- Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-; N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide; ACT 064992; Macitentan; Opsumit; Propylsulfamic acid N-[5-(4-bromophenyl)-6-[2-[(5-bromopyrimidin-2-yl)oxy]ethoxy]pyrimidin-4-yl]amide
- Sulfamide,N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-